Publications
Tuberculosis in migrant children and adolescents in Europe: A joint TBnet and ptbnet systematic review and meta-analysis
2026
Clinical Microbiology and Infection
Anca Vasiliu, Heinke Kunst, Folke Brinkmann
DOI:
10.1016/j.cmi.2026.07.014
Attitudes towards adjunctive surgical therapy for pulmonary TB in Europe: an ESGMYC, ESTS, and TBnet collaborative survey
2026
The International Journal of Tuberculosis and Lung Disease
(IJTDL)
Raja Idris, Nils Wetzstein
DOI:
10.5588/ijtld.25.0707
Action is needed to reduce TB drug shortages in Europe
2026
The International Journal of Tuberculosis and Lung Disease (IJTDL
Simone Tunesi, Lorenzo Guglielmetti, Liga Kuksa
DOI:
10.5588/ijtld.26.0154
Availability of mental health management in the context of TB diagnosis and during TB treatment across WHO European Region
2026
IJTDL Open
Christina Vilaplana, Olena Rzhepishevska, Olha Konstantynovska
DOI:
10.5588/ijtldopen.25.0661
A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2026 Update for Clinicians and Scientists
2026
Pathog Immun
Tunesi S, Bothamley G, Günther G et al
DOI:
10.20411/pai.v11i1.970
Tuberculosis incidence in solid organ transplant recipients in Europe: A multicenter TBnet cohort study.
2025
Journal of Infection
Lange B, Brehm TT, Arend SM et al
DOI:
10.1016/j.jinf.2025.106668
Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study
2025
The Lancet Regional Health - Europe
Martina Sester, Neus Altet-Gomez, Christoph Lange et al
DOI:
10.1016/j.lanepe.2025.101416
Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort study
2025
The Lancet Regional Health - Europe
Yousra Kherabi, Ole Skouvig Pedersen, Lorenzo Guglielmetti et al
DOI:
10.1016/j.lanepe.2025.101380
Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy
2025
IJTLDopen
Kuksa L, Andrejak C, Haecker B et al
DOI:
10.5588/ijtldopen.25.0152
A Year in Review on Tuberculosis and Non- tuberculous Mycobacteria Disease: A 2025 Update for Clinicians and Scientists
2025
Pathog Immun
Lange C, Bothamley G, Günther G et al
DOI:
10.20411/pai.v10i2.791
Tuberculosis in adult migrants in Europe: a TBnet consensus statement
2025
Eur Respir J
Kunst H, Lange B, Hovardovska O et al
DOI:
10.1183/13993003.01612-2024
Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in Europe
2025
IJTLD Open
Kirakosyan O, Reimann M, Andersen AB et al
DOI:
10.5588/ijtldopen.24.0498
Screening of refugees from Ukraine for TB: a TBnet survey
2024
Int J Tuberc Lung Dis
Argel M, Conde M, Vieira M et al
DOI:
10.5588/ijtld.23.0447
Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe
2024
Clin Microbiol Infect
Günther G, Guglielmetti L, Kherabi Y et al
DOI:
10.1016/j.cmi.2024.03.009
Tuberculosis disease in immunocompromised children and adolescents: a pTBnet multi-centre case-control study
2024
Clin Infect Dis
Rodríguez-Molino P, Tebruegge M, Noguera-Julian A et al
DOI:
10.1093/cid/ciae158